Maricann Group Inc. Receives Health Canada Approval for Phase One of Canadian Expansion
TORONTO, April 23, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI)(FRANKFURT:75M)(OTCQB:MRRCF)(“Maricann” or the “Company”), is pleased to announce that it has received all of the necessary approvals from Health Canada to commence cultivation in Phase One of the Company’s new, state-of-the-art grow facility in Langton, Ontario, Canada. This is Maricann’s third licence issued by Health Canada.
The licensing of Phase One of our Canadian expansion is a major milestone for both our employees and shareholders. This facility could be built in the Arctic, or the equator and still replicate the exact same cannabis every time. Due to the control and automation platform, combined with a unique building envelope design from standard stock, pre-engineered steel and greenhouse components, our overall costs are reduced.
Ben Ward, CEO
The design of the facility is revolutionary, combining the best of indoor cultivation and greenhouse technology. We utilize natural sunlight in a completely controlled, sealed, and energy efficient cultivation environment. Our automated process allows us to reduce ongoing operational costs to create a meaningful cost advantage.
Ward continued: “Environment and genetics are the two most critical elements in the production of cannabis. Our new facility, combined with Rare Dankness Cannabis Cup award winning genetics, provides Maricann with the ability to supply a superior product to the market. We invested significantly in a new purpose-built facility, with an optimal work flow that complies with GMP production standards and Six Sigma operations. This will result in ongoing low cost production of a premium quality product. We plan to bring our experience and expertise with us globally in replication of this world leading facility, designed by our VP of Infrastructure, Jeff Ayotte.”
Elements of the expansion include:
- Segmentation of cultivation rooms into 8,800 square feet, to create an optimal environment for each strain’s cultivation that can be individually controlled, mitigating risk in potential cross contamination with individual pressurization in each room;
- 1,550,000 litre cistern, recycling all water used in the facility through a seven layer organic biological pond, reducing waste water to less than 10,000 litres per year.
- R-38 Exterior building envelope
- Natural Gas co-generation electric facility to produce low cost electricity.
- Co2 scrubber, using the exhaust of the natural gas co-gen facility and boilers, cleaning and then using as a fertilizer for plants in the increase of Co2 in each cultivation room, instead of industry standard liquid Co2.
- Diffused glass roof, combined with supplemental LED lights to provide natural sunlight, and enhanced lumen penetration of the canopy.
About Maricann Group Inc.
Maricann is a vertically integrated producer and distributor of marijuana for medical purposes. The company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario, Canada where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada, and Dresden, Saxony, Germany. Maricann is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) build out, with a designed expected capacity of producing 95,000 kg (based on conservative estimates) of dry cannabis flower per year to support existing and future patient growth.
